Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study

Po-Cheng ShihPo-Cheng HungPui-Ying LeongJui-Ning HsuChieh-Chun YangJames Cheng Chung WeiHsin-Hua Chen2026-02-042026-02-042024-10-1110.1007/s10067-024-07161-6https://scholars.csmu.edu.tw/handle/123456789/5075Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort studyjournal-article